Search

everythinglearnresearchcommunity

for

Search:↓

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

Androgens increase a growth factor in hair cells by creating reactive oxygen species, and antioxidants might help treat hair loss.

The document concludes that hair transplantation and gene therapy may be important for future hair loss treatment.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

The exact cause of increased 5α-reductase activity leading to hirsutism in women is still unknown.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Scutellaria baicalensis extract and baicalin may help prevent hair loss.

Red deer only have androgen receptors in neck hair cells for mane growth during breeding season.

DHT stops hair regrowth in mice, similar to human hair loss.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Male hormones indirectly affect skin cell development by increasing growth factor levels from skin fibroblasts.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Early balding at 40 increases prostate cancer risk.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

The activity of a specific rat enzyme in the prostate and epididymis is highly dependent on the acidity level.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Hsc70 protein may influence hair growth by responding to androgens.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

High androgen levels can cause hirsutism and increase inflammation.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Gene variation affects prostate issues and hair loss.